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INTRODUCTION
Several analytical pipelines for identifying total copy number (TCN) events from DNA microarrays are available. However, certain types of genomic alterations cannot be detected from TCNs, e.g. copy neutral LOH events. The identification of such events can be key to our biological understanding of cancer development and our ability to set up a personalized treatment plan (Albertson et al., 2003) .
Genotyping microarrays (Affymetrix Inc., 2007; Peiffer et al., 2006) quantify not only TCNs but also allele-specific copy numbers (ASCNs), which are necessary to identify CN states such as copy neutral loss of heterozygosity LOH. ASCNs are the CN estimates of each allele variant (here A and B) at a particular (bi-allelic) singlenucleotide polymorphism (SNP). For the purpose of displaying ASCNs along the genome and also for detecting CN changes, ASCNs are often represented by their TCNs and B-allele fractions (BAFs) (Bengtsson et al., 2010) . For instance, for diploid SNPs in a Figure S4 normal region, the expected TCN is 2 and expected BAFs are 0 (AA), 1/2 (AB) or 1 (BB). In a region of copy neutral LOH, the expected TCN is 2 and the expected BAFs are 0 or 1. For a single-copy gain, expected TCN is 3 and expected BAFs are 0, 1/3, 2/3 and 1. In Figure 1 , observed TCNs and BAFs are displayed along the genome for a normal region, a gain and a region of copy neutral LOH.
Based on these type of data, segmentation methods (Chen et al., 2011; Olshen et al., 2011; Staaf et al., 2008; Van Loo et al., 2010) identify regions of constant CN state. Their performances depend greatly on the signal-to-noise ratios (SNRs) of TCN and BAF (Bengtsson et al., 2010) , which in turn depend on the preprocessing method used, e.g. dChip (Lin et al., 2004) , CN5 (Affymetrix Inc., 2007) , CRMA v2 (Bengtsson et al., 2009) , ACNE (Ortiz-Estevez et al., 2010) and 'Illumina' (Peiffer et al., 2006) . Some of these methods perform better than others. It would be favorable to borrow strength between them, but in practice it is impossible because the preprocessing methods are developed specifically for a given SNP platform or chip generation. In addition, methods may also be proprietary, making it infeasible for researchers to improve upon them. A more sustainable solution for improving SNRs is to instead develop normalization methods that operate on the ASCN output of the aforementioned methods. For matched tumor-normal SNP microarray experiments, Bengtsson et al. (2010) provide the platform-independent TumorBoost method, which significantly improves the BAFs of the tumor. Here, we propose CalMaTe (for Calibration Matrix T), which to our knowledge is the only ASCN processing pipeline that is open source, cross-platform and that does not require matched normals.
METHOD AND RESULTS
CalMaTe is a platform-independent multi-array method that controls for SNP-specific systematic variation by modeling the crosstalk between alleles in bi-allelic SNPs as explained next. Non-polymorphic loci (on recent SNP array platforms) are normalized by a robust average across samples.
CalMaTe SNP model. The main assumption of CalMaTe is that crosshybridization between alleles is linear and possibly different between SNPs but preserved across samples. Consider a SNP j = 1,...,J , and let H c j be the 2×I matrix with column vectors (C Aij ,C Bij ) T of the unobserved true ASCNs across all samples i = 1,...,I . The corresponding observed ASCNs H j can then be modeled as
where W j is an unknown 2×2 crosstalk matrix shared by all samples, and ε j is a 2×I error matrix. This model and its estimation are outlined below and explained in more detail in the Supplementary Materials.
Estimating the crosstalk. W j can be estimated from a set of normal samples ('R') for which the ASCNs (genotypes) are known, e.g. The set of possible states in H c j,R is discrete and small, which is why it is possible to estimateŴ j . There is no such constraint on H c j , which is key when analyzing non-homogeneous samples such as tumors. Given genotypes H c j,R and observed H j,R , an estimateŴ j is obtained by robustly solving Equation (1) for W j . CalMaTe calls the genotypes from H j,R using a naive genotyping algorithm. To minimize the impact of batch effects (Scharpf et al., 2011) , the reference samples are ideally in the same batch as the other samples. If normal samples are unavailable, all samples can be used as a reference. As long as the majority of the reference samples are normal at any given SNP (not necessarily the same samples for all SNPs), the robustness of the estimator warrants a goodŴ j estimate. We recommend to use 6 or more reference samples (see also Supplementary Materials).
Calibration of ASCNs.
Given an estimateŴ j , the calibrated ASCNs,H c j , are obtained from Equation (1) as the back-transformationH c j =T j H j , wherê
is the 2×2 calibration matrix.
Results. CalMaTe was applied to the TCGA-ovarian cancer dataset ((alias?)). The DNA was hybridized to Affymetrix GenomeWideSNP_6 arrays and ASCNs were estimated using CRMA v2. In Figure 1 , such ASCNs are shown as TCNs and BAFs before and after CalMaTe. CalMaTe improves the SNRs, as confirmed by extensive ROC analysis (Fig. 2 and Supplementary Materials), which makes it easier for segmentation methods to distinguish between different CN states. Similar improvements are achieved for ASCNs from dChip as well as ASCNs originating from Illumina, as shown in the Supplementary Materials. 
